1. Home
  2. OIA vs HRTX Comparison

OIA vs HRTX Comparison

Compare OIA & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OIA
  • HRTX
  • Stock Information
  • Founded
  • OIA 1988
  • HRTX 1983
  • Country
  • OIA United States
  • HRTX United States
  • Employees
  • OIA N/A
  • HRTX N/A
  • Industry
  • OIA Finance Companies
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OIA Finance
  • HRTX Health Care
  • Exchange
  • OIA Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • OIA 287.4M
  • HRTX 270.7M
  • IPO Year
  • OIA N/A
  • HRTX 1987
  • Fundamental
  • Price
  • OIA $6.07
  • HRTX $2.38
  • Analyst Decision
  • OIA
  • HRTX Strong Buy
  • Analyst Count
  • OIA 0
  • HRTX 3
  • Target Price
  • OIA N/A
  • HRTX $5.67
  • AVG Volume (30 Days)
  • OIA 97.9K
  • HRTX 2.7M
  • Earning Date
  • OIA 01-01-0001
  • HRTX 05-06-2025
  • Dividend Yield
  • OIA 4.88%
  • HRTX N/A
  • EPS Growth
  • OIA N/A
  • HRTX N/A
  • EPS
  • OIA N/A
  • HRTX N/A
  • Revenue
  • OIA N/A
  • HRTX $144,285,000.00
  • Revenue This Year
  • OIA N/A
  • HRTX $11.81
  • Revenue Next Year
  • OIA N/A
  • HRTX $15.79
  • P/E Ratio
  • OIA N/A
  • HRTX N/A
  • Revenue Growth
  • OIA N/A
  • HRTX 13.57
  • 52 Week Low
  • OIA $4.93
  • HRTX $1.04
  • 52 Week High
  • OIA $6.72
  • HRTX $3.93
  • Technical
  • Relative Strength Index (RSI)
  • OIA 49.98
  • HRTX 58.92
  • Support Level
  • OIA $5.91
  • HRTX $2.29
  • Resistance Level
  • OIA $6.17
  • HRTX $2.56
  • Average True Range (ATR)
  • OIA 0.07
  • HRTX 0.20
  • MACD
  • OIA -0.01
  • HRTX -0.01
  • Stochastic Oscillator
  • OIA 57.14
  • HRTX 46.43

About OIA Invesco Municipal Income Opportunities Trust

Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: